CynergisTek to Host a Conference Call on Thursday, March 24, 2022 to Discuss Fourth Quarter and Full Year 2021 Financial Results | Business

AUSTIN, Texas–(BUSINESS WIRE)–March 18, 2022–

CynergisTek (NYSE AMERICAN: CTEK), a leading cybersecurity, privacy, compliance and IT audit firm helping organizations in highly regulated industries address emerging security and privacy issues, today announced that management will host a conference call at 4:30 p.m. Eastern Time on Thursday. , March 24, 2022, to discuss fourth quarter and full year 2021 financial results. Results will be released prior to the call.

When: Thursday, March 24, 2022

Time: 4:30 p.m. ET / 1:30 p.m. PT

US: 1-888-256-1007

International: 1-786-789-4783

Conference ID: 1507111


A replay of the call will be available from 7:30 p.m. ET on March 24, 2022 to 11:59 p.m. ET on March 31, 2022. To access the replay, please dial 1-844-512-2921 from within the United States and 1-412-317-6671 from outside the US The PIN is 1507111.

About CynergisTek, Inc.

CynergisTek (, is a leading cybersecurity consulting firm that helps organizations in highly regulated industries, including healthcare, government and finance, manage emerging security and security issues. confidentiality. CynergisTek combines intelligence, expertise, and a distinct methodology to validate an organization’s security posture and ensure the team is primed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real world experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit or follow us on Twitter or LinkedIn.

Caution Regarding Forward-Looking Statements

This release contains certain forward-looking statements relating to the business of CynergisTek, Inc. These forward-looking statements have the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and may be identified by the use of forward-looking terminology such as “believes”, “expects”, “anticipates”, “would”, ” may”, “intends”, “may”, “will”, or similar expressions. These forward-looking statements involve known and unknown risks and uncertainties, including, but not limited to, uncertainties related to the product/service development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other suppliers; the ability of the Company’s suppliers to continue to be provided to the Company supplies and services on comparable terms and prices; the Company’s ability to successfully compete and introduce enhancements and new features that gain market acceptance and keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace significant customers; cybersecurity risks and risks of damage to and interruptions of computer systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new businesses, divestitures, mergers or other transactions on acceptable terms, or not at all; potential risks and uncertainties related to the current and ultimate impact of COVID-19, including geographic spread, severity of the virus, duration of the COVID-19 outbreak, actions that may be taken by government authorities to contain the COVID-19 outbreak or to address its impact, and the potential adverse impacts of COVID-19 on the global economy and financial markets, and other factors that may cause actual results to differ materially from those described here as anticipated, believed, estimated or expected. Some of these risks and uncertainties are or will be described in more detail in the Company’s Forms 10-K and 10-Q filed with the Securities and Exchange Commission, which are available at Given the risks and uncertainties, readers should not place undue reliance on forward-looking statements and should recognize that statements are predictions of future results which may not occur as expected. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not currently anticipated. CynergisTek has no obligation (and expressly disclaims any such obligation) to update or change its forward-looking statements, whether as a result of new information, future events or otherwise.

See the source version on

CONTACT: CynergisTek Investor Relations Contact: CynergisTek, Inc.

Bryan Flynn

(512) 402-8550 x7

[email protected] CynergisTek Media Contact: CynergisTek, Inc.

Trinity McPherson

(443) 853-8468

[email protected]



SOURCE: CynergisTek

Copyright BusinessWire 2022.

PUBLISHED: 03/18/2022 07:00 / DISK: 03/18/2022 07:02

Copyright BusinessWire 2022.

Michael P. Boser